Insider Transactions in Q2 2023 at Good Rx Holdings, Inc. (GDRX)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 14
2023
|
Agnes Rey Giraud Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,177
+35.0%
|
-
|
Jun 14
2023
|
Julie Mb Bradley Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,177
+29.14%
|
-
|
Jun 08
2023
|
Babak Azad |
SELL
Payment of exercise price or tax liability
|
Direct |
7,055
-13.82%
|
$35,275
$5.41 P/Share
|
Jun 08
2023
|
Babak Azad |
BUY
Exercise of conversion of derivative security
|
Direct |
20,401
+28.55%
|
-
|
Jun 08
2023
|
Romin Nabiey Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,528
-4.99%
|
$17,640
$5.41 P/Share
|
Jun 08
2023
|
Romin Nabiey Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,201
+12.6%
|
-
|
Jun 08
2023
|
Karsten Voermann Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,611
-12.96%
|
$83,055
$5.41 P/Share
|
Jun 08
2023
|
Karsten Voermann Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
54,064
+29.67%
|
-
|
Jun 01
2023
|
Trevor Bezdek Chairman |
BUY
Conversion of derivative security
|
Direct |
129,374
+12.1%
|
-
|
Jun 01
2023
|
Douglas Joseph Hirsch Director |
BUY
Conversion of derivative security
|
Direct |
129,374
+12.1%
|
-
|
May 20
2023
|
Raj Beri CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
43,797
-18.38%
|
$218,985
$5.08 P/Share
|
May 20
2023
|
Raj Beri CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
91,026
+27.64%
|
-
|
Apr 15
2023
|
Romin Nabiey Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
902
-1.47%
|
$4,510
$5.95 P/Share
|
Apr 15
2023
|
Romin Nabiey Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,606
+4.07%
|
-
|